Literature DB >> 2365192

Safety of azathioprine in pregnancy in inflammatory bowel disease.

E M Alstead1, J K Ritchie, J E Lennard-Jones, M J Farthing, M L Clark.   

Abstract

Although azathioprine has been reported to be safe during pregnancy in renal transplant recipients and patients with systemic lupus erythematosus, opinions vary whether it should be continued in pregnancy in inflammatory bowel disease. A retrospective analysis of the outcome of 16 pregnancies in 14 women receiving azathioprine for inflammatory bowel disease was performed. There was one infective complication of pregnancy (hepatitis B virus infection), but there were no congenital abnormalities or subsequent health problems in the children. This preliminary study suggests that azathioprine is safe in pregnancy in inflammatory bowel disease patients and that termination of pregnancy is not mandatory for those who conceive while taking the drug.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2365192     DOI: 10.1016/0016-5085(90)91027-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  47 in total

Review 1.  Inflammatory bowel disease in pregnancy.

Authors:  E M Alstead
Journal:  Postgrad Med J       Date:  2002-01       Impact factor: 2.401

Review 2.  Fertility and pregnancy in inflammatory bowel disease.

Authors:  E Alstead
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 3.  Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the future.

Authors:  Fokaline Vroom; Hermien E K de Walle; Mart A J F van de Laar; Jacobus R B J Brouwers; Lolkje T W de Jong-van den Berg
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  IBD and Pregnancy.

Authors:  Audrey H Calderwood; Sunanda V Kane
Journal:  MedGenMed       Date:  2004-10-08

Review 5.  Drug management of ulcerative colitis.

Authors:  M A Kamm; A Senapati
Journal:  BMJ       Date:  1992-07-04

Review 6.  Fertility and pregnancy in the patient with inflammatory bowel disease.

Authors:  U Mahadevan
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 7.  A meta-analysis on the influence of inflammatory bowel disease on pregnancy.

Authors:  J Cornish; E Tan; J Teare; T G Teoh; R Rai; S K Clark; P P Tekkis
Journal:  Gut       Date:  2006-12-21       Impact factor: 23.059

Review 8.  Inflammatory bowel disease and pregnancy: evidence, uncertainty and patient decision-making.

Authors:  Flavio M Habal; Varun Kapila
Journal:  Can J Gastroenterol       Date:  2009-01       Impact factor: 3.522

Review 9.  Immune thrombocytopenia and pregnancy.

Authors:  Srividhya Sankaran; Susan E Robinson
Journal:  Obstet Med       Date:  2011-10-25

10.  The long-term risk of continuous immunosuppression using thioguanides in inflammatory bowel disease.

Authors:  Anthony O'Connor; Asghar Qasim; Colm A O'Moráin
Journal:  Ther Adv Chronic Dis       Date:  2010-01       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.